A change in blood transcriptional signatures accompanies successful tuberculosis therapy

C. Bloom, C. Graham, M. Berry, K. Wilkinson, O. Tolu, F. Rozakeas, Z. Xu, J. Rossello-Urgell, D. Chaussabel, J. Banchereau, V. Pascual, M. Lipman, R. Wilkinson, A. O‘Garra (London, United Kingdom; Cape Town, South Africa; Dallas, United States Of America)

Source: Annual Congress 2012 - Tuberculous and non-tuberculous mycobacterial infections: diagnostic tools
Session: Tuberculous and non-tuberculous mycobacterial infections: diagnostic tools
Session type: Thematic Poster Session
Number: 2640
Disease area: Respiratory infections

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
C. Bloom, C. Graham, M. Berry, K. Wilkinson, O. Tolu, F. Rozakeas, Z. Xu, J. Rossello-Urgell, D. Chaussabel, J. Banchereau, V. Pascual, M. Lipman, R. Wilkinson, A. O‘Garra (London, United Kingdom; Cape Town, South Africa; Dallas, United States Of America). A change in blood transcriptional signatures accompanies successful tuberculosis therapy. Eur Respir J 2012; 40: Suppl. 56, 2640

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Can genomic signatures predict response to systemic therapy?
Source: Annual Congress 2013 –Biological signatures in thoracic oncology
Year: 2013


A novel whole-blood miRNA signature for a rapid diagnosis of pulmonary tuberculosis
Source: Eur Respir J 2015; 45: 1173-1176
Year: 2015


TB following targeted and biological therapy: can we predict it?
Source: Virtual Congress 2020 – Tuberculosis and comorbidities
Year: 2020


The peculiarities of course and treatment of pulmonary tuberculosis with initial drug resistance
Source: Eur Respir J 2003; 22: Suppl. 45, 41s
Year: 2003

Assessment of the dynamics of focal changes after the intensive phase of treatment in patients with sensitive and resistant pulmonary tuberculosis
Source: Virtual Congress 2020 – Multidrug-resistant tuberculosis
Year: 2020


Role of haptogobins genetically determined phenotypes in the development, treatment and prevention pulmonary tuberculosis
Source: Annual Congress 2010 - Prognosis of tuberculosis
Year: 2010

T-cell biomarkers for diagnosis of tuberculosis: candidate evaluation by a simple whole blood assay for clinical translation
Source: Eur Respir J, 51 (3) 1800153; 10.1183/13993003.00153-2018
Year: 2018



Peripheral blood leukocyte subsets as markers of early TB treatment response
Source: Annual Congress 2005 - Management of tuberculosis pulmonary, extrapulmonary peculiarities
Year: 2005


Regulation of apoptosis via the PARK7 interactome in peripheral blood mononuclear cells donated by tuberculosis patients vs. controls and the response to treatment: a systems biology approach.
Source: International Congress 2018 – New developments in tuberculosis
Year: 2018

Monitoring T-cell immunity towards M. tuberculosis: impaired specific immunocompetence in patients receiving high levels of immunosuppressive drugs
Source: Annual Congress 2008 - Genetics, immunology and microbiology of tuberculosis
Year: 2008


Basic factors, influencing treatment efficacy of patients with newly detected sputum positive destructive lung tuberculosis
Source: Eur Respir J 2004; 24: Suppl. 48, 724s
Year: 2004

Frequently used inflammation markers and their role in monitoring tuberculosis treatment
Source: Annual Congress 2008 - Diagnosis of tuberculosis: problems and perspectives
Year: 2008

Role of adaptive immunity in clinical variability of active tuberculosis patients
Source: Virtual Congress 2021 – Novel imaging analysis methodologies in diffuse lung diseases
Year: 2021


A sputum gene expression signature predicts oral corticosteroid response in asthma
Source: Eur Respir J, 49 (6) 1700180; 10.1183/13993003.00180-2017
Year: 2017



Predicting outcomes and drug resistance with standardised treatment of active tuberculosis
Source: Eur Respir J 2010; 36: 870-877
Year: 2010



Factors associated with delay in treatment initiation for pulmonary tuberculosis
Source: ERJ Open Res, 6 (1) 00161-2019; 10.1183/23120541.00161-2019
Year: 2020



Central/effector memory T-cell dynamics in the peripheral blood of patients with active pulmonary tuberculosis
Source: Eur Respir J 2002; 20: Suppl. 38, 10s
Year: 2002

In silico analysis of tuberculosis and multiple sclerosis gene expression profiles reveals coregulated genes implicated in host response to pathogens.
Source: International Congress 2017 – Human susceptibility to tuberculosis
Year: 2017


Tuberculosis therapy: past, present and future
Source: Eur Respir J 2002; 20: 87S-94S
Year: 2002